USPTO serial 79456193
VORONOI
Reviewed by CopyMark Law Group
Status 640Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- SINGH, DEEP K
- Law office
- TMEG LAW OFFICE 101
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with VORONOI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations and compositions for the treatment and prevention of protein kinase-related diseases; pharmaceutical preparations for treating metabolic disorders; cardiovascular pharmaceutical preparations; cardiovascular treatment preparations; pharmaceutical preparations and compositions for the treatment and prevention of cancer; biopharmaceutical preparations for the treatment of cancer; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the prevention of inflammatory diseases; pharmaceutical preparations for the treatment of inflammatory diseases; chemical preparations for medical purposes, namely, for the treatment of cancer; enzymes for medical purposes; pharmaceutical compositions for use in treatment and prevention of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; pharmaceutical preparations for cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for treating tumors; pharmaceutical preparations for the diagnosis of cancer; pharmaceutical preparations for neurodegenerative diseases; pharmaceutical preparations for the treatment of Parkinson's disease; pharmaceutical preparations for the treatment of lung cancer; antidiabetic preparations | ACTIVE | — |
| 042 | Medical diagnostic assays for analyzing proteins; database design and development; scientific research conducted using databases; research relating to molecular sciences; research and development services of new pharmaceutical products using molecular modelling; research laboratory analysis services in the field of molecular biology; development of computer software for big data processing; technical data analysis services in the field of biotechnology; development of pharmaceuticals for cell therapies; development, updating and maintenance of software and database systems; drug discovery services; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; consultancy relating to pharmaceutical research and development; technical consultancy in the field of development of computer software for analyzing medical and biotechnological data; providing personalized medical data interpretation services, namely, medical data analysis services; research services in the field of pharmaceutical preparations; consultancy in the field of testing, inspection, research of pharmaceutical products; providing information on the testing, inspection and research of pharmaceutical products; medical and pharmacological research services; development of computer hardware for artificial intelligence services; research and development of computer software platforms for artificial intelligence services; development of computer software for artificial intelligence services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 30, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 29, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 29, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 31, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 31, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 28, 2026 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Aug 13, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |